Literature DB >> 22138996

Isolation and characterization of enterocin W, a novel two-peptide lantibiotic produced by Enterococcus faecalis NKR-4-1.

Naruhiko Sawa1, Pongtep Wilaipun, Seisuke Kinoshita, Takeshi Zendo, Vichien Leelawatcharamas, Jiro Nakayama, Kenji Sonomoto.   

Abstract

Enterococcus faecalis NKR-4-1 isolated from pla-ra produces a novel two-peptide lantibiotic, termed enterocin W, comprising Wα and Wβ. The structure of enterocin W exhibited similarity with that of plantaricin W. The two peptides acted synergistically, and their order of binding to the cell membrane was important for their inhibitory activity.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22138996      PMCID： PMC3264125          DOI： 10.1128/AEM.06497-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  13 in total

1.  Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor.

Authors:  A Katsumi; E A Tuley; I Bodó; J E Sadler
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Synergistic antimicrobial activity of metabolites produced by a nonobligate bacterial predator.

Authors:  Cody C Cain; Dongho Lee; Robert H Waldo; Alexis T Henry; Earl J Casida; Mansukh C Wani; Monroe E Wall; Nicholas H Oberlies; Joseph O Falkinham
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.

Authors:  Nathaniel I Martin; Tara Sprules; Michael R Carpenter; Paul D Cotter; Colin Hill; R Paul Ross; John C Vederas
Journal:  Biochemistry       Date:  2004-03-23       Impact factor: 3.162

4.  Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.

Authors:  N Sawa; K Okamura; T Zendo; K Himeno; J Nakayama; K Sonomoto
Journal:  J Appl Microbiol       Date:  2009-12-15       Impact factor: 3.772

5.  Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic.

Authors:  M C Booth; C P Bogie; H G Sahl; R J Siezen; K L Hatter; M S Gilmore
Journal:  Mol Microbiol       Date:  1996-09       Impact factor: 3.501

6.  Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics.

Authors:  Helge Holo; Zoran Jeknic; Mark Daeschel; Stefan Stevanovic; Ingolf F Nes
Journal:  Microbiology       Date:  2001-03       Impact factor: 2.777

7.  The chromatographic determination of cystine and cysteine residues in proteins as s-beta-(4-pyridylethyl)cysteine.

Authors:  M Friedman; L H Krull; J F Cavins
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

Review 8.  Two-peptide bacteriocins produced by lactic acid bacteria.

Authors:  Sylvie Garneau; Nathaniel I Martin; John C Vederas
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

9.  Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5.

Authors:  Hideo Yonezawa; Howard K Kuramitsu
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

10.  Enhancement of cyanogen bromide cleavage yields for methionyl-serine and methionyl-threonine peptide bonds.

Authors:  R Kaiser; L Metzka
Journal:  Anal Biochem       Date:  1999-01-01       Impact factor: 3.365
View more
  12 in total

1.  Bacteriocin protein BacL1 of Enterococcus faecalis targets cell division loci and specifically recognizes L-Ala2-cross-bridged peptidoglycan.

Authors:  Jun Kurushima; Daisuke Nakane; Takayuki Nishizaka; Haruyoshi Tomita
Journal:  J Bacteriol       Date:  2014-11-03       Impact factor: 3.490

2.  Partial Diversity Generates Effector Immunity Specificity of the Bac41-Like Bacteriocins of Enterococcus faecalis Clinical Strains.

Authors:  Jun Kurushima; Yasuyoshi Ike; Haruyoshi Tomita
Journal:  J Bacteriol       Date:  2016-08-11       Impact factor: 3.490

Review 3.  Natural bacterial isolates as an inexhaustible source of new bacteriocins.

Authors:  Jelena Lozo; Ljubisa Topisirovic; Milan Kojic
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

4.  Using the overlay assay to qualitatively measure bacterial production of and sensitivity to pneumococcal bacteriocins.

Authors:  Natalie Maricic; Suzanne Dawid
Journal:  J Vis Exp       Date:  2014-09-30       Impact factor: 1.355

5.  Enterocin F4-9, a Novel O-Linked Glycosylated Bacteriocin.

Authors:  Mohamed Abdelfattah Maky; Naoki Ishibashi; Takeshi Zendo; Rodney Honrada Perez; Jehan Ragab Doud; Mohamed Karmi; Kenji Sonomoto
Journal:  Appl Environ Microbiol       Date:  2015-05-08       Impact factor: 4.792

Review 6.  Bacteriocins from lactic acid bacteria and their potential clinical applications.

Authors:  Abigail Fernandes; Renitta Jobby
Journal:  Appl Biochem Biotechnol       Date:  2022-03-15       Impact factor: 3.094

7.  Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.

Authors:  Shradha Basi-Chipalu; Jasmin Dischinger; Michaele Josten; Christiane Szekat; Annegret Zweynert; Hans-Georg Sahl; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

Review 8.  Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications.

Authors:  Rodney H Perez; Takeshi Zendo; Kenji Sonomoto
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

9.  Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation.

Authors:  Ahmed K Al Atya; Yanath Belguesmia; Gabrielle Chataigne; Rozenn Ravallec; Anne Vachée; Sabine Szunerits; Rabah Boukherroub; Djamel Drider
Journal:  Front Microbiol       Date:  2016-05-31       Impact factor: 5.640

10.  Bovicin HJ50-like lantibiotics, a novel subgroup of lantibiotics featured by an indispensable disulfide bridge.

Authors:  Jian Wang; Hongchu Ma; Xiaoxuan Ge; Jie Zhang; Kunling Teng; Zhizeng Sun; Jin Zhong
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.